ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
ICMR-led consultation calls for stricter HFSS regulations, nutrition literacy, and healthier food environments
The company reported net revenue of SEK 13.5 million for the full year 2025
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
Subscribe To Our Newsletter & Stay Updated
